STOCK TITAN

T. Rowe Price (TRNS) filing shows only 59 Transcat shares held

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G to report its holdings in Transcat Inc. (TRNS) common stock. The firm reports beneficial ownership of 59 shares, representing 0.0% of the class as of the reported date.

The filer states it has sole voting and dispositive power over these 59 shares and no shared power. It also indicates that it now owns 5 percent or less of Transcat’s common stock and that the position is held in the ordinary course of business, not to influence control of the company, while expressly denying beneficial ownership of the securities referenced.

Positive

  • None.

Negative

  • None.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



T. Rowe Price Investment Management, Inc.
Signature:Ellen York
Name/Title:Vice President
Date:02/17/2026

FAQ

What did T. Rowe Price report in its amended Schedule 13G for TRNS?

T. Rowe Price Investment Management, Inc. reported beneficial ownership of 59 shares of Transcat Inc. common stock, equal to 0.0% of the class. The filing reflects its current holdings and confirms it now owns 5 percent or less of this security class.

How many Transcat (TRNS) shares does T. Rowe Price beneficially own?

The firm reports beneficial ownership of 59 shares of Transcat Inc. common stock. It has sole voting and sole dispositive power over these 59 shares, with no shared voting or shared dispositive power reported in the filing.

What percentage of Transcat (TRNS) does T. Rowe Price’s position represent?

T. Rowe Price Investment Management, Inc. states its 59 Transcat shares represent 0.0% of the class. The filing also notes this reflects ownership of 5 percent or less of Transcat’s common stock, indicating only a very small residual stake.

Is T. Rowe Price seeking to influence control of Transcat (TRNS)?

No. T. Rowe Price certifies the securities were acquired and are held in the ordinary course of business. It states they were not acquired and are not held to change or influence control of Transcat, aligning with passive investment intent language.

Does T. Rowe Price claim full beneficial ownership of the TRNS shares?

The firm expressly denies beneficial ownership of the securities referenced. While the Schedule 13G lists 59 shares with sole voting and dispositive power, T. Rowe Price states that the filing should not be construed as an admission of beneficial ownership.

When did the Transcat (TRNS) ownership level triggering this filing occur?

The event requiring this amended Schedule 13G is dated 12/31/2025. That date marks the ownership status used in the report, with T. Rowe Price Investment Management, Inc. listing 59 beneficially owned shares and a corresponding 0.0% stake in Transcat’s common stock.